Trevena Inc.: Clinical Trials

3 trials sponsored by Trevena Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Trevena Inc.: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty
Oliceridine, Placebo, Morphine - Acute Pain
Phase 3CompletedTrevena Inc.4072016-05-012020-10-23
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy
Oliceridine, Placebo, Morphine - Acute Pain
Phase 3CompletedTrevena Inc.4182016-05-012020-09-25
A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain
TRV130 - Acute Pain
Phase 3CompletedTrevena Inc.7682015-12-012020-09-24

Conditions studied

Acute Pain (3)

Interventions

((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (3)  ·  Morphine (2)

Countries

United States (3)

Top investigators

Franck Skobieranda, MD (3)

Results publications

PMID 31162798, PMID 31814753